<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>JAK2 | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of JAK2 Mutation Testing  Definition: Molecular testing for mutations in the JAK2 gene (Janus kinase 2) is used to diagnose and classify certain myeloproliferative neoplasms (MPNs)...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="JAK2 | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of JAK2 Mutation Testing  Definition: Molecular testing for mutations in the JAK2 gene (Janus kinase 2) is used to diagnose and classify certain myeloproliferative neoplasms (MPNs)...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="JAK2 | Hematology">
<meta name="twitter:description" content="Overview of JAK2 Mutation Testing  Definition: Molecular testing for mutations in the JAK2 gene (Janus kinase 2) is used to diagnose and classify certain myeloproliferative neoplasms (MPNs)...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="active" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary-1.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Microbiology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="jak2" class="section level1 unnumbered">
<h1>JAK2<a class="anchor" aria-label="anchor" href="#jak2"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-jak2-mutation-testing" class="section level2 unnumbered">
<h2>
<strong>Overview of <em>JAK2</em> Mutation Testing</strong><a class="anchor" aria-label="anchor" href="#overview-of-jak2-mutation-testing"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> Molecular testing for mutations in the <em>JAK2</em> gene (Janus kinase 2) is used to diagnose and classify certain myeloproliferative neoplasms (MPNs)</li>
<li>
<strong>Clinical Significance:</strong>
<ul>
<li>Diagnosis of MPNs: A <em>JAK2</em> mutation, particularly <em>JAK2</em> V617F, is a major diagnostic criterion for Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF)</li>
<li>Differential Diagnosis: Helps distinguish MPNs from other conditions with similar clinical features (e.g., secondary erythrocytosis, reactive thrombocytosis)</li>
<li>Prognosis: Certain <em>JAK2</em> mutations may have prognostic significance in some MPNs</li>
<li>Therapeutic Decision-Making: JAK2 inhibitors are used to treat MPNs with <em>JAK2</em> mutations</li>
</ul>
</li>
<li>
<strong>Key Mutations:</strong>
<ul>
<li>
<em>JAK2</em> V617F: The most common mutation, found in the majority of PV cases and approximately 50-60% of ET and PMF cases</li>
<li>
<em>JAK2</em> Exon 12 Mutations: Less common, primarily found in PV patients who are <em>JAK2</em> V617F-negative</li>
</ul>
</li>
</ul>
</div>
<div id="the-jak2-gene-and-its-function" class="section level2 unnumbered">
<h2>
<strong>The <em>JAK2</em> Gene and Its Function</strong><a class="anchor" aria-label="anchor" href="#the-jak2-gene-and-its-function"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Gene Location:</strong> The <em>JAK2</em> gene is located on chromosome 9p24</li>
<li>
<strong>Protein Product:</strong> <em>JAK2</em> encodes Janus kinase 2, a non-receptor tyrosine kinase that is essential for signal transduction from various cytokine receptors</li>
<li>
<strong>Function:</strong>
<ul>
<li>
<em>JAK-STAT Signaling Pathway:</em> JAK2 is a key component of the JAK-STAT signaling pathway, which is involved in hematopoiesis, immune function, and cell growth</li>
<li>
<em>Cytokine Receptor Signaling:</em> When cytokines (e.g., erythropoietin, thrombopoietin, granulocyte colony-stimulating factor) bind to their receptors on the cell surface, they activate JAK2</li>
<li>
<em>Phosphorylation:</em> Activated JAK2 phosphorylates (adds phosphate groups to) STAT proteins (signal transducers and activators of transcription)</li>
<li>
<em>Transcription Activation:</em> Phosphorylated STATs dimerize and translocate to the nucleus, where they bind to DNA and activate the transcription of genes involved in cell proliferation, differentiation, and survival</li>
</ul>
</li>
</ul>
</div>
<div id="pathophysiology-of-jak2-mutations-in-mpns" class="section level2 unnumbered">
<h2>
<strong>Pathophysiology of <em>JAK2</em> Mutations in MPNs</strong><a class="anchor" aria-label="anchor" href="#pathophysiology-of-jak2-mutations-in-mpns"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Constitutive Activation:</strong> <em>JAK2</em> mutations, particularly <em>JAK2</em> V617F, result in constitutive activation of the JAK-STAT signaling pathway
<ul>
<li>The V617F mutation causes the JAK2 protein to be constantly active, even in the absence of cytokine stimulation</li>
</ul>
</li>
<li>
<strong>Uncontrolled Cell Proliferation:</strong> The constitutive activation of JAK-STAT leads to:
<ul>
<li>Increased proliferation of myeloid cells (erythrocytes, granulocytes, megakaryocytes)</li>
<li>Cytokine Independence: Hematopoietic cells become less dependent on cytokines for their survival and proliferation</li>
</ul>
</li>
<li>
<strong>Specific Effects in MPNs:</strong>
<ul>
<li>Polycythemia Vera (PV): Increased sensitivity to EPO leads to erythrocytosis</li>
<li>Essential Thrombocythemia (ET): Increased sensitivity to thrombopoietin leads to thrombocytosis</li>
<li>Primary Myelofibrosis (PMF): Activation of signaling pathways leads to increased megakaryocyte proliferation, release of fibrogenic cytokines, and bone marrow fibrosis</li>
</ul>
</li>
</ul>
</div>
<div id="laboratory-methods-for-detecting-jak2-mutations" class="section level2 unnumbered">
<h2>
<strong>Laboratory Methods for Detecting <em>JAK2</em> Mutations</strong><a class="anchor" aria-label="anchor" href="#laboratory-methods-for-detecting-jak2-mutations"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Polymerase Chain Reaction (PCR)-Based Assays:</strong>
<ul>
<li>
<em>Principle:</em> PCR is used to amplify a specific region of the <em>JAK2</em> gene that contains the V617F mutation or exon 12 mutations.</li>
<li>
<em>Methods:</em>
<ul>
<li>Allele-Specific PCR (AS-PCR): Uses primers that are specific for the mutated sequence</li>
<li>Quantitative Real-Time PCR (RQ-PCR): Measures the amount of the mutated sequence relative to the normal sequence</li>
</ul>
</li>
<li>
<em>Advantages:</em>
<ul>
<li>High sensitivity and specificity</li>
<li>Relatively rapid turnaround time</li>
</ul>
</li>
<li>
<em>Limitations:</em>
<ul>
<li>Only detects known mutations for which primers are available</li>
<li>Cannot detect novel mutations or other genetic abnormalities</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Next-Generation Sequencing (NGS):</strong>
<ul>
<li>
<em>Principle:</em> Massively parallel sequencing technology that allows for the simultaneous sequencing of multiple genes, including <em>JAK2</em>
</li>
<li>
<em>Procedure:</em>
<ul>
<li>DNA is extracted from bone marrow aspirate or peripheral blood</li>
<li>Targeted sequencing: Only the coding regions of specific genes (e.g., <em>JAK2, CALR, MPL</em>) are sequenced</li>
<li>Whole-exome sequencing: The entire coding region of the genome is sequenced</li>
<li>The sequencing data are analyzed to identify gene mutations, insertions, deletions, and copy number variations</li>
</ul>
</li>
<li>
<em>Advantages:</em>
<ul>
<li>Can detect both known and novel mutations</li>
<li>Can detect multiple mutations simultaneously</li>
<li>Can be used to identify gene expression changes</li>
</ul>
</li>
<li>
<em>Limitations:</em>
<ul>
<li>More complex and expensive than PCR-based methods</li>
<li>Requires bioinformatics expertise for data analysis</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="interpreting-results-1" class="section level2 unnumbered">
<h2>
<strong>Interpreting Results</strong><a class="anchor" aria-label="anchor" href="#interpreting-results-1"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong><em>JAK2</em> V617F Positive:</strong> Indicates the presence of the <em>JAK2</em> V617F mutation</p>
<ul>
<li>Supports a diagnosis of PV, ET, or PMF</li>
<li>Quantitative results from RQ-PCR can be used to monitor treatment response</li>
</ul>
</li>
<li>
<p><strong><em>JAK2</em> Exon 12 Mutation Positive:</strong> Indicates the presence of a mutation in exon 12 of the <em>JAK2</em> gene</p>
<ul>
<li>Supports a diagnosis of PV in patients who are <em>JAK2</em> V617F-negative</li>
</ul>
</li>
<li>
<p><strong><em>JAK2</em> Mutation Negative:</strong> Does not rule out an MPN</p>
<ul>
<li>Consider testing for <em>CALR</em> and <em>MPL</em> mutations in <em>JAK2</em>-negative patients with suspected ET or PMF</li>
<li>Evaluate other diagnostic criteria (e.g., bone marrow morphology, clinical features)</li>
</ul>
</li>
<li>
<p><strong>Variant Allele Frequency (VAF):</strong></p>
<ul>
<li>The percentage of alleles that contain the mutation</li>
<li>In general, a higher VAF is associated with greater disease burden</li>
</ul>
</li>
<li>
<p><strong>Somatic vs. Germline Mutations:</strong></p>
<ul>
<li>
<em>JAK2</em> mutations are typically somatic (acquired) mutations that are only present in the hematopoietic cells</li>
<li>Rarely, <em>JAK2</em> mutations can be germline (inherited), which may predispose to MPNs</li>
</ul>
</li>
</ul>
</div>
<div id="reporting-results-15" class="section level2 unnumbered">
<h2>
<strong>Reporting Results</strong><a class="anchor" aria-label="anchor" href="#reporting-results-15"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>Clearly indicate the presence or absence of the <em>JAK2</em> V617F mutation or exon 12 mutations</li>
<li>Report the quantitative results (if applicable) and the methodology used</li>
<li>Provide an interpretation of the results, noting any limitations or qualifications</li>
<li>Correlate the molecular findings with the patient’s clinical, morphologic, and cytogenetic data</li>
</ul>
</div>
<div id="key-terms-74" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-74"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>JAK2* (Janus Kinase 2):</strong> A tyrosine kinase involved in signal transduction</li>
<li>
<strong>JAK2* V617F:</strong> A point mutation in the <em>JAK2</em> gene that is commonly found in MPNs</li>
<li>
<strong>JAK2* Exon 12 Mutations:</strong> Mutations in exon 12 of the <em>JAK2</em> gene that are primarily found in PV patients who are <em>JAK2</em> V617F-negative</li>
<li>
<strong>Myeloproliferative Neoplasm (MPN):</strong> A clonal hematopoietic stem cell disorder characterized by the overproduction of one or more blood cell lines</li>
<li>
<strong>Polycythemia Vera (PV):</strong> MPN with increased red blood cell production</li>
<li>
<strong>Essential Thrombocythemia (ET):</strong> MPN with increased platelet production</li>
<li>
<strong>Primary Myelofibrosis (PMF):</strong> MPN characterized by bone marrow fibrosis</li>
<li>
<strong>PCR (Polymerase Chain Reaction):</strong> A technique to amplify specific DNA sequences</li>
<li>
<strong>Next-Generation Sequencing (NGS):</strong> A high-throughput sequencing technology</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  l = [];
  function hide_label() {
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? l.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    count = 0;
    prev_elem = '';
    l.forEach((elem) => {
      if(count === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_elem.classList.add('hide_label');
        } else {
          prev_elem.classList.remove('hide_label');
        }
      }
      prev_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="bcrabl1.html">BCR/ABL1</a></div>
<div class="next"><a href="coagulation-pathways.html">Coagulation Pathways</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#jak2">JAK2</a></li>
<li><a class="nav-link" href="#overview-of-jak2-mutation-testing">Overview of JAK2 Mutation Testing</a></li>
<li><a class="nav-link" href="#the-jak2-gene-and-its-function">The JAK2 Gene and Its Function</a></li>
<li><a class="nav-link" href="#pathophysiology-of-jak2-mutations-in-mpns">Pathophysiology of JAK2 Mutations in MPNs</a></li>
<li><a class="nav-link" href="#laboratory-methods-for-detecting-jak2-mutations">Laboratory Methods for Detecting JAK2 Mutations</a></li>
<li><a class="nav-link" href="#interpreting-results-1">Interpreting Results</a></li>
<li><a class="nav-link" href="#reporting-results-15">Reporting Results</a></li>
<li><a class="nav-link" href="#key-terms-74">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Microbiology/blob/blob/main/Rmd/04-29-laboratory-determinations-molecular-cytogenetic-jak2.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Microbiology/blob/edit/main/Rmd/04-29-laboratory-determinations-molecular-cytogenetic-jak2.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-04-04 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
